Skip to content

Ready to Act - Health Education in People With Hyperglycaemia

Ready to Act. A Health Education Programme for People With Screen-detected Hyperglycaemia

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT01945645
Enrollment
509
Registered
2013-09-18
Start date
2006-09-30
Completion date
2010-12-31
Last updated
2013-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Behavior, Type 2 Diabetes Mellitus

Keywords

Prevention, Screening, Type 2 diabetes, Action Competence, Family practice, Health Services Research

Brief summary

A pre-randomized study in primary health care was designed to investigate health education in a subpopulation extracted from general practitioners (GPs) in one Danish county in the treatment arm of the ADDITION (Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care) study, DK. The overall objective of the 'Ready to Act' health education programme was to support the participants' competences in daily life and act appropriately with respect to their dysglycaemic condition. The achievement of action competence involved four learning objectives: intrinsic motivation, informed decision-making, action experience and social involvement. The programme was delivered in primary care settings (health centre or GP surgeries) by nurses, dieticians, physiotherapists and GPs.

Interventions

BEHAVIORALReady to act

The Ready to Act programme aimed to promote health-related action competence including motivation, informed decision-making, action experience and social involvement The intervention was delivered across a number of primary care settings including the GP office, health centre and pharmacy. The programme consisted of two individual counselling interviews and eight group sessions, which totalled 18 hours within a three month period.

Sponsors

University of Aarhus
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
PREVENTION
Masking
SINGLE (Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
40 Years to 69 Years
Healthy volunteers
Yes

Inclusion criteria

* age 40-69 years at the time of screening and diagnosed with screen-detected T2D, IGT or IFG (according to WHO criteria).

Exclusion criteria

* women who were pregnant or lactating, those with a psychotic illness or an illness with a prognosis of less than one year.

Design outcomes

Primary

MeasureTime frameDescription
Modelled cardiovascular disease risk3 years after intervention, dec 2010The risk is measured by a SCORE model uses information on age, sex, smoking status, total cholesterol and systolic blood pressure. It provides an estimate of ten-year fatal cardiovascular disease risk

Secondary

MeasureTime frameDescription
se-cholesterol3 years after intervention, dec 2010Serum cholesterol is the total amount of cholesterol found in the blood.
Patient ActivationOne year and three year (2006, 2007, 2010)The Patient Activation Measure (PAM-13) is a composite measure of perceived skills, self-efficacy and knowledge.
Glycated hemoglobin3 years after intervention, dec 2010Glycated hemoglobin (HbA1c)is a form of hemoglobin that is measured primarily to identify the average plasma glucose concentration over prolonged periods of time
Physical activity3 years after intervention, dec 2010Physical activity was measured using the International Physical Activity questionnaire (IPAQ-short form)
Smoking3 years after intervention, 2010Smoking status was assessed by standard questions.
Blood pressure3 years after intervention, dec 2010Systolic and diastolic blood pressure were measured

Countries

Denmark

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026